MEDI5752
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for MEDI5752, covering 2024-06-24 to 2026-06-09. Get the full timeline:
Most recent: Clinical Trial Update: MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma [Phase 3]